Ukr.Biochem.J. 2014; Volume 86, Issue 6, Nov-Dec, pp. 74-83


Expression of phosphoribosyl pyrophosphate synthetase genes in U87 glioma cells with ERN1 knockdown: effect of hypoxia and endoplasmic reticulum stress

O. H. Minchenko, I. A. Garmash, O. V. Kovalevska,
D. O. Tsymbal, D. O. Minchenko

Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;

Activation of pentose phosphate pathway is an important factor of enhanced cell proliferation and tumor growth. Phosphoribosyl pyrophosphate synthetase (PRPS) is a key enzyme of this pathway and plays a central role in the synthesis of purines and pyrimidines. Hypoxia as well as ERN1 (from endoplasmic reticulum to nuclei-1) mediated endoplasmic reticulum stress response-signalling pathway is linked to the proliferation because the blockade of ERN1 suppresses tumor growth, including glioma. We studied the expression of different PRPS genes in glioma cells with ERN1 knockdown under hypoxic condition. It was shown that hypoxia decreases the expression of PRPS1 and PRPS2 genes in both types of glioma cells, being more pronounced in cells without ERN1 function, but PRPSAP1 and PRPSAP2 gene expressions are suppressed by hypoxia only in glioma cells with blockade of ERN1. Moreover, the blockade of endoribonuclease activity of ERN1 does not affect the expression of PRPS1 and PRPS2 as well as PPRS-associated protein genes in U87 glioma cells. At the same time, the induction of endoplasmic reticulum stress by tunicamycin in glioma cells with suppressed activity of ERN1 endoribonuclease decreases the expression level of PRPS1 and PRPS2 genes only. Results of this investigation clearly demonstrated that the expression of different genes encoding subunits of PRPS enzyme is affected by hypoxia in U87 glioma cells, but the effect of hypoxia is modified by suppression of endoplasmic reticulum stress signaling enzyme ERN1.

Keywords: , , , , , , , ,


  1. Wang S, Kaufman RJ. The impact of the unfolded protein response on human disease. J Cell Biol. 2012 Jun 25;197(7):857-67. Review. PubMed, PubMedCentral, CrossRef
  2. Iizasa T. Increased activity of PRPP synthetase. Nihon Rinsho. 2008 Apr;66(4):694-8. Review. Japanese. PubMed
  3. Moenner M, Pluquet O, Bouchecareilh M, Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 2007 Nov 15;67(22):10631-4. Review. PubMed, CrossRef
  4. Mannava S, Grachtchouk V, Wheeler LJ, Im M, Zhuang D, Slavina EG, Mathews CK, Shewach DS, Nikiforov MA. Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells. Cell Cycle. 2008 Aug;7(15):2392-400. PubMed, PubMedCentral, CrossRef
  5. de Brouwer AP, van Bokhoven H, Nabuurs SB, Arts WF, Christodoulou J, Duley J. PRPS1 mutations: four distinct syndromes and potential treatment. Am J Hum Genet. 2010 Apr 9;86(4):506-18. Review. PubMed, PubMedCentral, CrossRef
  6. Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, Harding H, Novoa I, Varia M, Raleigh J, Scheuner D, Kaufman RJ, Bell J, Ron D, Wouters BG, Koumenis C. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 2005 Oct 5;24(19):3470-81. PubMed, PubMedCentral, CrossRef
  7. Fels DR, Koumenis C. The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther. 2006 Jul;5(7):723-8. Review. PubMed, CrossRef
  8. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, Yoshida H, Mori K, Glimcher LH, Denko NC, Giaccia AJ, Le QT, Koong AC. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 2004 Sep 1;64(17):5943-7. PubMed, CrossRef
  9. Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD. XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell. 2007 Jul 6;27(1):53-66. PubMed, CrossRef
  10. Schröder M. Endoplasmic reticulum stress responses. Cell Mol Life Sci. 2008 Mar;65(6):862-94. Review. PubMed
  11. Lin JH, Walter P, Yen TS. Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol. 2008;3:399-425. Review. PubMed, PubMedCentral
  12. Marciniak SJ, Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev. 2006 Oct;86(4):1133-49. Review. PubMed, CrossRef
  13. Hollien J, Lin JH, Li H, Stevens N, Walter P, Weissman JS. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol. 2009 Aug 10;186(3):323-31. Epub 2009 Aug 3. PubMed, PubMedCentral, CrossRef
  14. Aragón T, van Anken E, Pincus D, Serafimova IM, Korennykh AV, Rubio CA, Walter P. Messenger RNA targeting to endoplasmic reticulum stress signalling sites. Nature. 2009 Feb 5;457(7230):736-40. Epub 2008 Dec 14. PubMed, PubMedCentral, CrossRef
  15. Lee SK, Kim YS. Phosphorylation of eIF2α attenuates statin-induced apoptosis by inhibiting the stabilization and translocation of p53 to the mitochondria. Int J Oncol. 2013 Mar;42(3):810-6. Epub 2013 Jan 23. PubMed, PubMedCentral, CrossRef
  16. Drogat B, Auguste P, Nguyen DT, Bouchecareilh M, Pineau R, Nalbantoglu J, Kaufman RJ, Chevet E, Bikfalvi A, Moenner M. IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res. 2007 Jul 15;67(14):6700-7.
    PubMed, CrossRef
  17. Auf G, Jabouille A, Guérit S, Pineau R, Delugin M, Bouchecareilh M, Magnin N, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M. Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma. Proc Natl Acad Sci USA. 2010 Aug 31;107(35):15553-8.  PubMed, PubMedCentralCrossRef
  18. Auf G, Jabouille A, Delugin M, Guérit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M. High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor. BMC Cancer. 2013 Dec 13;13:597. PubMed, PubMedCentral, CrossRef
  19. Fridman A, Saha A, Chan A, Casteel DE, Pilz RB, Boss GR. Cell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate. Biochem J. 2013 Aug 15;454(1):91-9. PubMed, CrossRef
  20. Bardeleben C, Sharma S, Reeve JR, Bassilian S, Frost P, Hoang B, Shi Y, Lichtenstein A. Metabolomics identifies pyrimidine starvation as the mechanism of 5-aminoimidazole-4-carboxamide-1-β-riboside-induced apoptosis in multiple myeloma cells. Mol Cancer Ther. 2013 Jul;12(7):1310-21. PubMed, PubMedCentral, PubMed
  21. Minchenko DO, Garmash IA, Bashta YM, Kustkova GS, Zalesna YD, Bikfalvi A, Minchenko OH. ERN1 dependent expression of phosphoribosyl pyrophosphate synthetase genes in U87 glioma cells: effect of glucose or glutamine deprivation. Int J Genomic Med. 2013;1(1):104.
  22. Minchenko DО, Kubajchuk KІ, Ratushna OO, Komisarenko SV, Minchenko OH. The vascular endothelial growth factor genes expression in glioma U87 cells is dependent from ERN1 signaling enzyme function. Adv Biol Chem. 2012;2(2):198-206. CrossRef
  23. Minchenko DO, Karbovskyi LL, Dani­lovskyi SV, Kharkova A P, Minchenko OH. Expression of casein kinase genes in glioma cell line U87: effect of hypoxia and glucose or glutamine deprivation. Nat Sci. 2012;4(1):38-46.  CrossRef
  24. Minchenko DO, Karbovskyi LL, Dani­lovskyi SV, Moenner M, Minchenko OH. Effect of hypoxia and glutamine or glucose deprivation on the expression of retinoblastoma and retinoblastoma-related genes in ERN1 knockdown glioma U87 cell line. Am J Mol Biol. 2012;2(1):21-31.  CrossRef
  25. Minchenko DO, Kharkova AP, Hubenia OV, Minchenko OH. Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRA D, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and glutamine or glucose deprivation. Endocr Regul. 2013 Jan;47(1):15-26. PubMedCrossRef
  26. Wamelink MM, Struys EA, Jakobs C. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis. 2008 Dec;31(6):703-17. Review. PubMed, CrossRef
  27. Berry GT. The unexplored potential of the pentose phosphate pathway in health and disease. J Inherit Metab Dis. 2008 Dec;31(6):661. PubMed, CrossRef
  28. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le QT, Giaccia AJ. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell. 2009 Sep 24;35(6):856-67. PubMed, PubMedCentral, CrossRef
  29. Kumar S, Mehta K. Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway. PLoS One. 2012;7(11):e49321. PubMed, PubMedCentral, CrossRef
  30. He Y, Kim H, Ryu T, Kang Y, Kim JA, Kim BH, Lee JH, Kang K, Lu Q, Kim K. δ-Catenin overexpression promotes angiogenic potential of CWR22Rv-1 prostate cancer cells via HIF-1α and VEGF. FEBS Lett. 2013 Jan 16;587(2):193-9. PubMed, CrossRef
  31. Erpolat OP, Gocun PU, Akmansu M, Ozgun G, Akyol G. Hypoxia-related molecules HIF-1α, CA9, and osteopontin : predictors of survival in patients with high-grade glioma. Strahlenther Onkol. 2013 Feb;189(2):147-54. PubMed, CrossRef
  32. Chen C, Cai S, Wang G, Cao X, Yang X, Luo X, Feng Y, Hu J. c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α. Biochem Biophys Res Commun. 2013 Jan 11;430(2):505-11. PubMed, CrossRef
  33. Azar R, Lasfargues C, Bousquet C, Pyronnet S. Contribution of HIF-1α in 4E-BP1 gene expression. Mol Cancer Res. 2013 Jan;11(1):54-61. PubMed, CrossRef
  34. Fallone F, Britton S, Nieto L, Salles B, Muller C. ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression. Oncogene. 2013 Sep 12;32(37):4387-96.  PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.